JWA
VIR icon

JFS Wealth Advisors’s Vir Biotechnology VIR Stock Holding History

JFS Wealth Advisors’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$153 Buy
+15
New +$143 ﹤0.01% 2189
2024
Q3 		– Sell
-26
Closed -$232 – 2021
2024
Q2 		$232 Hold
26
– – ﹤0.01% 1889
2024
Q1 		$264 Hold
26
– – ﹤0.01% 1868
2023
Q4 		$262 Buy
26
+25
+2,500% +$228 ﹤0.01% 1876
2023
Q3 		$10 Hold
1
– – ﹤0.01% 1962
2023
Q2 		$25 Buy
+1
New +$25 ﹤0.01% 1965

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JFS Wealth Advisors's VIR Position: Q2 2026 in Review

JFS Wealth Advisors opened a new position in Vir Biotechnology (VIR) in Q2 2026: 15 shares worth $153. The stake represents ﹤0.01% of the portfolio and ranks #2189 among its holdings. This is a return to the name: JFS Wealth Advisors previously reported a position in VIR as recently as Q2 2024.

JFS Wealth Advisors first reported a position in VIR in Q2 2023 and has held it in 6 quarters since. The position peaked at $264 in Q1 2024. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • JFS Wealth Advisors held 15 shares of Vir Biotechnology worth $153 as of Q2 2026.
  • Vir Biotechnology was a new JFS Wealth Advisors position in Q2 2026.
  • Vir Biotechnology made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #2189 holding.
  • JFS Wealth Advisors first reported a position in Vir Biotechnology in Q2 2023 and has held it in 6 quarters since.
  • JFS Wealth Advisors's Vir Biotechnology position peaked at $264 in Q1 2024.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.